ACW
Actinogen Medical Ltd
Biotechnology
·
Healthcare
2
comments
1
fund manager
past 90 days
About Actinogen Medical Ltd
Actinogen Medical Ltd. is an Australian clinical-stage biotechnology company headquartered in Sydney. Founded in 1999 by Geoff E. D. Brooke and David Keast, the firm develops novel treatments for cognitive impairment linked to neurological, psychiatric, and metabolic diseases driven by elevated cortisol. Actinogen focuses on addressing unmet medical needs through innovative therapeutic research.
Commentary Volume
2
Comments
1
Fund managers
0
Past 90 days
SOURCE
ACTION
COMMENT PREVIEW
FUND MANAGER
DATE
Loading...
.
​Loading...
Loading...
Loading...
Loading...
Source: Ipsum Capital Q4 Quarterly Letter · Published 14 March 2025
Report a problem
Loading...
.
Loading...
Loading...
Loading...
Loading...
§ Important Notice
The entries below are records originating from third-party statements. Thesis Tracker does not rank, recommend or endorse any fund manager, fund or security. Investment decisions should be made on the basis of the relevant Product Disclosure Statement and, where appropriate, advice from a licensed adviser.
Commentary
Sector
Healthcare
Market cap
$11M
Fund managers
1 manager
First covered
28 Feb 2025
Last updated
30 Nov 2025
Company Details
Related Themes
ic
Ipsum Capital
6 comments
ic
Amet Funds
4 comments
ic
Dolor
3 comments
Top Investors Covering MIN
§ Reminder
The entries above are records originating from third-party statements. Thesis Tracker does not rank, recommend or endorse any fund manager, fund or security. Investment decisions should be made on the basis of the relevant Product Disclosure Statement and, where appropriate, advice from a licensed adviser.
Frequently asked questions about Actinogen Medical Ltd (ASX:ACW)
Frequently asked questions
Who is investing in Actinogen Medical Ltd (ASX:ACW)?
Fund managers including Pengana Capital Group have invested in Actinogen Medical Ltd (ASX:ACW).
What is the short interest in Actinogen Medical Ltd (ASX:ACW)?
The short interest in Actinogen Medical Ltd (ASX:ACW) is 0.01% which makes it the 521st most shorted stock on the ASX. Of the 3.2B shares that Actinogen Medical Ltd has on issue, 271.1K have been sold short.
What does Actinogen Medical Ltd (ASX:ACW) do?
Actinogen Medical Ltd. is an Australian clinical-stage biotechnology company headquartered in Sydney. Founded in 1999 by Geoff E. D. Brooke and David Keast, the firm develops novel treatments for cognitive impairment linked to neurological, psychiatric, and metabolic diseases driven by elevated cortisol. Actinogen focuses on addressing unmet medical needs through innovative therapeutic research.
Loading...